Umeclidinium Bromide

Preferred Label : Umeclidinium Bromide;

NCIt definition : The bromide salt form of umeclidinium, a muscarinic receptor antagonist, with bronchodilator activity. Although it does not display selectivity for specific muscarinic receptors, on topical application, umeclidinium acts mainly on M3 muscarinic receptors located on smooth muscle cells, thereby preventing smooth muscle contraction and resulting in bronchodilatory effect.;

UNII : 7AN603V4JV;

InChIKey : PEJHHXHHNGORMP-UHFFFAOYSA-M;

CAS number : 869113-09-7;

Drug name : Incruse;

Molecule name : GSK-573719A; GSK 573719A;

Details

Origin ID

C152797;

UMLS CUI

C3709474;

Automatic exact mappings (from CISMeF team)
- umeclidinium bromide [ATC Code]
Currated CISMeF NLP mapping
- Umeclidinium bromide [ICD-11 Extension code]
- Umeclidinium bromide [SMS substance]
- Umeclidinium bromide (substance) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Umeclidinium bromide (substance) [SNOMED CT concept]
- umeclidinium bromide [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients